HPV frequency in oral cavity and oropharynx cancers and its association with immune checkpoint inhibitors

Objectives: The prevalence of human papillomavirus (HPV) associated oropharyngeal squamous cell carcinomas (SqCCs) varies ethnically and geographically and has better prognostic features compared to HPV negative cases. Escaping from the immune system is one of the important mechanisms in the development of oropharyngeal SCC. The interaction of programmed cell death receptor 1 (PD-1) and its ligand (PD-L1) causes T cell suppression. In our study, we aimed to evaluate the frequency of HPV and its relation with PD-1/PD-L1, which is closely related to lymphoid tissue and important in prognosis and treatment in oral cavity and oropharynx SCCs. Method: We retrospectively investigated the presence of HPV in sections prepared from paraffin blocks of biopsy and excision materials by immunohistochemical staining method with p16 antibody and HPV in-situ hybridization (ISH) method in our series of 70 patients diagnosed with oral (SqHC). We also evaluated PD-L1 expression in tumor cells and PD-1 expression in lymphoid cells in the tumor microenvironment by immunohistochemically staining method. Results: HPV positivity was detected in three tumors, two in the oropharynx and one lateral to the tongue. PD-L1 positivity was observed in 45 (64.3%) cases. PD-1 expression was moderate or severe in 75.6% of PD-L1 positive cases and 24% of PD-L1 negative cases and this ratio was statistically significant. PD-L1 positivity was detected in only one of the 3 HPV positive cases. There was no significant difference in overall survival in PD-L1 positive patients compared to PD-L1 negative ones. Discussion: PD-1 or PD-L1 expression can be observed in oral cavity and oropharynx SCC regardless of HPV status. Although HPV positivity is frequently reported to be associated with good prognosis, studies are limited especially in our country. The prognostic and predictive importance of these biomarkers should be supported by more comprehensive studies.

Authors

Institutions

Publication Details

Journal
Türk tıp dergisi.
Published
2024-12-11
DOI
https://doi.org/10.70852/tmj.1589582
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HPV frequency in oral cavity and oropharynx cancers and its association with immune checkpoint inhibitors

Hayriye Tatlı Doğan, Mustafa Tahtacı
Türk tıp dergisi.
Head and Neck Cancer Studies
article

HPV frequency in oral cavity and oropharynx cancers and its association with immune checkpoint inhibitors

Hayriye Tatlı Doğan, Mustafa Tahtacı
article en

Abstract

Objectives: The prevalence of human papillomavirus (HPV) associated oropharyngeal squamous cell carcinomas (SqCCs) varies ethnically and geographically and has better prognostic features compared to HPV negative cases. Escaping from the immune system is one of the important mechanisms in the development of oropharyngeal SCC. The interaction of programmed cell death receptor 1 (PD-1) and its ligand (PD-L1) causes T cell suppression. In our study, we aimed to evaluate the frequency of HPV and its relation with PD-1/PD-L1, which is closely related to lymphoid tissue and important in prognosis and treatment in oral cavity and oropharynx SCCs. Method: We retrospectively investigated the presence of HPV in sections prepared from paraffin blocks of biopsy and excision materials by immunohistochemical staining method with p16 antibody and HPV in-situ hybridization (ISH) method in our series of 70 patients diagnosed with oral (SqHC). We also evaluated PD-L1 expression in tumor cells and PD-1 expression in lymphoid cells in the tumor microenvironment by immunohistochemically staining method. Results: HPV positivity was detected in three tumors, two in the oropharynx and one lateral to the tongue. PD-L1 positivity was observed in 45 (64.3%) cases. PD-1 expression was moderate or severe in 75.6% of PD-L1 positive cases and 24% of PD-L1 negative cases and this ratio was statistically significant. PD-L1 positivity was detected in only one of the 3 HPV positive cases. There was no significant difference in overall survival in PD-L1 positive patients compared to PD-L1 negative ones. Discussion: PD-1 or PD-L1 expression can be observed in oral cavity and oropharynx SCC regardless of HPV status. Although HPV positivity is frequently reported to be associated with good prognosis, studies are limited especially in our country. The prognostic and predictive importance of these biomarkers should be supported by more comprehensive studies.

Türk tıp dergisi.
Ankara Yıldırım Beyazıt University (TR)
Good health and well-being
Openalex Percentile: Top 59%
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

HPV frequency in oral cavity and oropharynx cancers and its association with immune checkpoint inhibitors — Hayriye Tatlı Doğan, Mustafa Tahtacı · Türk tıp dergisi. (2024) | TGRS Research Map | TGRS